Position in JNJ
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$9,391,556
+$292,522 QoQ
Shares Held
36,979
-0.7% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
2.92%
of 13F equity value
Holder Rank
#1,149
of 4,664 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Calydon Capital holds $35,751,780 across 10 Drug Manufacturers - General names. JNJ ranks #1 (26.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
This page
|
36,979 | $9,391,556 | |
| 2 | GILD |
Gilead Sciences, Inc.
|
58,233 | $7,357,157 | |
| 3 | AMGN |
Amgen Inc
|
20,308 | $7,353,932 | |
| 4 | BMY |
Bristol Myers Squibb Co
|
123,497 | $7,115,897 | |
| 5 | LLY |
ELI LILLY & Co
|
1,509 | $1,809,940 | |
| 6 | AZN |
Astrazeneca PLC
|
4,923 | $933,499 | |
| 7 | NVS |
Novartis AG
|
5,755 | $901,923 | |
| 8 | MRK |
Merck & Co., Inc.
|
2,772 | $356,202 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $9,391,556 | 36,979 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $9,099,034 | 37,224 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $7,944,810 | 38,390 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $7,105,479 | 38,321 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $6,571,610 | 43,022 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $6,451,341 | 38,901 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $4,994,017 | 34,532 | Shares | Sole | 2025-02-18 | |
| 2024-09-30 | $5,427,065 | 33,488 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $6,217,500 | 42,539 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $6,901,196 | 43,626 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $5,194,206 | 33,139 | Shares | Sole | 2024-02-07 | |
| 2023-09-30 | $5,185,073 | 33,291 | Shares | Sole | 2023-11-01 | |
| 2023-06-30 | $5,423,262 | 32,765 | Shares | Sole | 2023-08-21 | |
| 2023-03-31 | $5,148,325 | 33,215 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $5,694,842 | 32,238 | Shares | Sole | 2023-02-15 | |
| 2022-09-30 | $5,269,176 | 32,255 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $6,259,180 | 35,261 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $6,167,249 | 34,798 | Shares | Sole | 2022-05-05 | |
| 2021-12-31 | $5,685,511 | 33,235 | Shares | Sole | 2022-02-07 | |
| 2021-09-30 | $4,914,445 | 30,430 | Shares | Sole | 2021-11-10 | |
| 2021-06-30 | $5,033,136 | 30,552 | Shares | Sole | 2021-08-10 | |
| 2021-03-31 | $12,961,955 | 78,868 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $4,034,751 | 25,637 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $4,131,568 | 27,751 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $4,030,877 | 28,663 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $4,805,783 | 36,649 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||